Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease

Naoki Uchida, Kotaro Takasaki, Yuri Sakata, Ai Nogami, Hiroshi Oishi, Takuya Watanabe, Taro Shindo, Nobuaki Egashira, Kaori Kubota, Shutaro Katsurabayashi, Kenichi Mishima, Michihiro Fujiwara, Ryoji Nishimura, Katsunori Iwasaki

研究成果: ジャーナルへの寄稿記事

25 引用 (Scopus)

抄録

The aim of this study was to investigate the effect of Yokukansan (YKS) on the impairment of spatial memory and cholinergic involvement in a rat model of early-phase Alzheimer's disease (AD). In this model, rats underwent four-vessel transient cerebral ischemia and then were treated with beta amyloid oligomers injected intracerebroventricularly once daily for 7 days. These animals showed memory impairment in an eight-arm radial maze task without histological evidence of apoptosis but with a decrease in expression of hippocampal dynamin 1, an important factor in synaptic vesicle endocytosis. Oral administration of YKS for 2 weeks significantly increased the number of correct choices and decreased the number of error choices in the eight-arm radial maze task (P < 0.05). Moreover, YKS significantly increased high K+-evoked potentiation of acetylcholine (ACh) release (P < 0.05) and significantly increased the expression of dynamin 1 (P < 0.01) in the hippocampus. The ameliorative effect of YKS on spatial memory impairment in our rat model of early-phase AD may be mediated in part by an increase in ACh release and modulation of dynamin 1 expression, leading to improved synaptic function. Future studies will determine whether YKS is similarly useful in the treatment of memory defects in patients diagnosed with early-stage AD.

元の言語英語
ページ(範囲)966-972
ページ数7
ジャーナルPhytotherapy Research
27
発行部数7
DOI
出版物ステータス出版済み - 7 1 2013

Fingerprint

Dynamin I
Cholinergic Agents
Alzheimer Disease
Acetylcholine
Synaptic Vesicles
Transient Ischemic Attack
Endocytosis
Amyloid
Oral Administration
Hippocampus
Yi-Gan San
Spatial Memory
Apoptosis

All Science Journal Classification (ASJC) codes

  • Pharmacology

これを引用

Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease. / Uchida, Naoki; Takasaki, Kotaro; Sakata, Yuri; Nogami, Ai; Oishi, Hiroshi; Watanabe, Takuya; Shindo, Taro; Egashira, Nobuaki; Kubota, Kaori; Katsurabayashi, Shutaro; Mishima, Kenichi; Fujiwara, Michihiro; Nishimura, Ryoji; Iwasaki, Katsunori.

:: Phytotherapy Research, 巻 27, 番号 7, 01.07.2013, p. 966-972.

研究成果: ジャーナルへの寄稿記事

Uchida, N, Takasaki, K, Sakata, Y, Nogami, A, Oishi, H, Watanabe, T, Shindo, T, Egashira, N, Kubota, K, Katsurabayashi, S, Mishima, K, Fujiwara, M, Nishimura, R & Iwasaki, K 2013, 'Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease', Phytotherapy Research, 巻. 27, 番号 7, pp. 966-972. https://doi.org/10.1002/ptr.4818
Uchida, Naoki ; Takasaki, Kotaro ; Sakata, Yuri ; Nogami, Ai ; Oishi, Hiroshi ; Watanabe, Takuya ; Shindo, Taro ; Egashira, Nobuaki ; Kubota, Kaori ; Katsurabayashi, Shutaro ; Mishima, Kenichi ; Fujiwara, Michihiro ; Nishimura, Ryoji ; Iwasaki, Katsunori. / Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease. :: Phytotherapy Research. 2013 ; 巻 27, 番号 7. pp. 966-972.
@article{fdf6770b47684229ac1a890727e691ac,
title = "Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease",
abstract = "The aim of this study was to investigate the effect of Yokukansan (YKS) on the impairment of spatial memory and cholinergic involvement in a rat model of early-phase Alzheimer's disease (AD). In this model, rats underwent four-vessel transient cerebral ischemia and then were treated with beta amyloid oligomers injected intracerebroventricularly once daily for 7 days. These animals showed memory impairment in an eight-arm radial maze task without histological evidence of apoptosis but with a decrease in expression of hippocampal dynamin 1, an important factor in synaptic vesicle endocytosis. Oral administration of YKS for 2 weeks significantly increased the number of correct choices and decreased the number of error choices in the eight-arm radial maze task (P < 0.05). Moreover, YKS significantly increased high K+-evoked potentiation of acetylcholine (ACh) release (P < 0.05) and significantly increased the expression of dynamin 1 (P < 0.01) in the hippocampus. The ameliorative effect of YKS on spatial memory impairment in our rat model of early-phase AD may be mediated in part by an increase in ACh release and modulation of dynamin 1 expression, leading to improved synaptic function. Future studies will determine whether YKS is similarly useful in the treatment of memory defects in patients diagnosed with early-stage AD.",
author = "Naoki Uchida and Kotaro Takasaki and Yuri Sakata and Ai Nogami and Hiroshi Oishi and Takuya Watanabe and Taro Shindo and Nobuaki Egashira and Kaori Kubota and Shutaro Katsurabayashi and Kenichi Mishima and Michihiro Fujiwara and Ryoji Nishimura and Katsunori Iwasaki",
year = "2013",
month = "7",
day = "1",
doi = "10.1002/ptr.4818",
language = "English",
volume = "27",
pages = "966--972",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease

AU - Uchida, Naoki

AU - Takasaki, Kotaro

AU - Sakata, Yuri

AU - Nogami, Ai

AU - Oishi, Hiroshi

AU - Watanabe, Takuya

AU - Shindo, Taro

AU - Egashira, Nobuaki

AU - Kubota, Kaori

AU - Katsurabayashi, Shutaro

AU - Mishima, Kenichi

AU - Fujiwara, Michihiro

AU - Nishimura, Ryoji

AU - Iwasaki, Katsunori

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The aim of this study was to investigate the effect of Yokukansan (YKS) on the impairment of spatial memory and cholinergic involvement in a rat model of early-phase Alzheimer's disease (AD). In this model, rats underwent four-vessel transient cerebral ischemia and then were treated with beta amyloid oligomers injected intracerebroventricularly once daily for 7 days. These animals showed memory impairment in an eight-arm radial maze task without histological evidence of apoptosis but with a decrease in expression of hippocampal dynamin 1, an important factor in synaptic vesicle endocytosis. Oral administration of YKS for 2 weeks significantly increased the number of correct choices and decreased the number of error choices in the eight-arm radial maze task (P < 0.05). Moreover, YKS significantly increased high K+-evoked potentiation of acetylcholine (ACh) release (P < 0.05) and significantly increased the expression of dynamin 1 (P < 0.01) in the hippocampus. The ameliorative effect of YKS on spatial memory impairment in our rat model of early-phase AD may be mediated in part by an increase in ACh release and modulation of dynamin 1 expression, leading to improved synaptic function. Future studies will determine whether YKS is similarly useful in the treatment of memory defects in patients diagnosed with early-stage AD.

AB - The aim of this study was to investigate the effect of Yokukansan (YKS) on the impairment of spatial memory and cholinergic involvement in a rat model of early-phase Alzheimer's disease (AD). In this model, rats underwent four-vessel transient cerebral ischemia and then were treated with beta amyloid oligomers injected intracerebroventricularly once daily for 7 days. These animals showed memory impairment in an eight-arm radial maze task without histological evidence of apoptosis but with a decrease in expression of hippocampal dynamin 1, an important factor in synaptic vesicle endocytosis. Oral administration of YKS for 2 weeks significantly increased the number of correct choices and decreased the number of error choices in the eight-arm radial maze task (P < 0.05). Moreover, YKS significantly increased high K+-evoked potentiation of acetylcholine (ACh) release (P < 0.05) and significantly increased the expression of dynamin 1 (P < 0.01) in the hippocampus. The ameliorative effect of YKS on spatial memory impairment in our rat model of early-phase AD may be mediated in part by an increase in ACh release and modulation of dynamin 1 expression, leading to improved synaptic function. Future studies will determine whether YKS is similarly useful in the treatment of memory defects in patients diagnosed with early-stage AD.

UR - http://www.scopus.com/inward/record.url?scp=84879943926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879943926&partnerID=8YFLogxK

U2 - 10.1002/ptr.4818

DO - 10.1002/ptr.4818

M3 - Article

C2 - 22888033

AN - SCOPUS:84879943926

VL - 27

SP - 966

EP - 972

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 7

ER -